Product Information
Atripla is manufactured by Bristol-Myers-Squibb and Gilead Sciences, LLC.Atripla (efavirenz, emtricitabine, tenofovir)tablets are a combination of three widely used antiretroviral drugs that are taken as one tablet (one per day) for the treatment of human immunodeficiency virus -1 (HIV-1) infection in adult patients. Atripla tablets can be taken alone or combination with other medicines to treat HIV-1.
Atripla (Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate) is an antiretroviral combination medicine used alone or with other medicines to treat human immunodeficiency virus (HIV) infection in adults.
Atripla combines three drugs (efavirenz, emtricitabine, tenofovir) in a single pill also known as a fixed-dose combination package having three drugs in a single pill.
The most common side effects of Atripla include headache, dizziness, abdominal pain, nausea, vomiting, and rash.
SEVERE AND SOMETIMES FATAL LACTIC ACIDOSIS (buildup of lactic acid in the blood) has occurred in some patients taking medicines similar to Atripla.
This risk may be greater in women, obese/overweight patients, those who have been taking nucleoside medicines (such as emtricitabine) for a long time. CONTACT YOUR DOCTOR IMMEDIATELY if you develop extreme weakness or tiredness; unusual muscle pain; trouble breathing; stomach pain with nausea or vomiting; cold feeling, especially in the arms and legs; severe or persistent dizziness or lightheadedness; or fast or irregular heartbeat.
Very serious and/or fatal liver problems have occurred in some patients taking medicine similar to Atripla. It is very important to contact your doctor as soon as possible if you develop conditions such as yellowing of the skin or eyes, dark urine, pale stools, loss of appetite, severe or persistent nausea, or stomach pain.
Atripla (Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate) offers a one pill, once a day treatment option for patients receiving antiretroviral therapy. This was done to simlify the dosing of HIV meds and encourage patients to take all their medications by encouraging compliance.
Swallow ATRIPLA with water.
Taking ATRIPLA at bedtime may make some side effects less bothersome.
Do not miss a dose of ATRIPLA. If you forget to take ATRIPLA, take the missed dose right away, unless it is almost time for your next dose. It is important not to miss Atripla Doses because the amount of virus in your blood may increase if the medicine is stopped for even a short time. The virus may develop resistance to ATRIPLA and become harder to treat.
Atripla (Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate)is not indicated for use in patients with chronic Hepatitis B infection. However, discontinuation of the treatment for HIV-1 with Atripla in patients with chronic Hepatitis B infection can result in severe flare-ups of Hepatitis B infection. Other potential serious adverse events reported for the use of Atripla
